CRISPR-Based Diagnostics: A Potential Tool to Address the Diagnostic Challenges of Tuberculosis
暂无分享,去创建一个
[1] F. He,et al. Development of an MSPQC Nucleic Acid Sensor Based on CRISPR/Cas9 for the Detection of Mycobacterium tuberculosis. , 2022, Analytical chemistry.
[2] H. Deng,et al. A Highly Sensitive and Specific Detection Method for Mycobacterium tuberculosis Fluoroquinolone Resistance Mutations Utilizing the CRISPR-Cas13a System , 2022, Frontiers in Microbiology.
[3] Irene N Njuguna,et al. CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study , 2022, The Lancet. Microbe.
[4] Yanju Chen,et al. Advances in amplification-free detection of nucleic acid: CRISPR/Cas system as a powerful tool. , 2022, Analytical biochemistry.
[5] M. Eisenstein. Seven technologies to watch in 2022 , 2022, Nature.
[6] Fei Huang,et al. Global control of tuberculosis: current status and future prospects , 2022 .
[7] Xingxu Huang,et al. A Recombinase Polymerase Amplification-Coupled Cas12a Mutant-Based Module for Efficient Detection of Streptomycin-Resistant Mutations in Mycobacterium tuberculosis , 2022, Frontiers in Microbiology.
[8] Xiong Zhu,et al. LAMP-CRISPR-Cas12-based diagnostic platform for detection of Mycobacterium tuberculosis complex using real-time fluorescence or lateral flow test , 2021, Microchimica Acta.
[9] Shiyuan Li,et al. TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis. , 2021, The Journal of infection.
[10] A. Kostyusheva,et al. CRISPR-Cas systems for diagnosing infectious diseases , 2020, Methods.
[11] Xiaolong Liu,et al. An isothermal method for sensitive detection of Mycobacterium tuberculosis complex using CRISPR/Cas12a cis- and trans-cleavage. , 2020, The Journal of molecular diagnostics : JMD.
[12] Ashutosh Kumar Singh,et al. Diagnostic performance of non-invasive, stool-based molecular assays in patients with paucibacillary tuberculosis , 2020, Scientific Reports.
[13] Teng Xu,et al. CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis , 2019, Emerging microbes & infections.
[14] Alimuddin Zumla,et al. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. , 2018, The Lancet. Infectious diseases.
[15] Hayden C. Metsky,et al. Field-deployable viral diagnostics using CRISPR-Cas13 , 2018, Science.
[16] Jennifer A. Doudna,et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity , 2018, Science.
[17] Aviv Regev,et al. Nucleic acid detection with CRISPR-Cas13a/C2c2 , 2017, Science.
[18] Peter J Dodd,et al. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling , 2016, PLoS medicine.